Journal Article

Prevalence of the HLA-B5701 Allele and Abacavir Hypersensitivity in Saudi HIV Patients: A Multicenter Study

Alsaeed, Ali, Abu Ali, Batool, Al muhainy, Badr, Alkhadrawi, Zahra, Alhadad, Fadel, Alhaddad, Taher A, Alhaddad, Mousa J, Alsadah, Batool, Almudhry, Zakia, AlBayat, Hawra, Dahlawi, Albaraa

2023

Overview

IntroductionHuman immunodeficiency virus (HIV) incidence and prevalence are increasing in Saudi Arabia, with a total prevalence of 12,000 in 2020. Treatment of HIV patients includes multiple regimens that may involve abacavir (ABC), which is a potent drug for treating HIV and can be used as a single or combined pill. Unfortunately, its use was limited by the known associated hypersensitivity reaction (HSR). A worldwide literature review over the past decades reported that the incidence of ABC-related HSR is 5-8%.MethodsThe study was a cross-sectional multicentric study involving five governmental hospitals in Saudi Arabia and included all HIV patients who were following in these centers.ResultsOut of 3082 patients, 1293 were tested for HLA-B*5701. The prevalence for ABC-HSR is 1.59%, with variability among the five hospitals, with the highest in King Fahad Hospital in Hafuf (KFH-H) at 4.00% and the lowest in Dammam Medical Complex (DMC) at 0.49%. In previous studies, HLA-B*5701 associated with ABC-HSR varied among different ethnic groups. Our study showed that two patients developed ABC-HSR clinically while they were both negative for HLA-B*5701.ConclusionThe fact that patients with negative genetic testing are still at risk of developing ABC-HSR makes continuing screening for HLA-B*5701 status essential, as the consequences of missing such a life-threatening HSR could be detrimental.

• Publisher: Springer Nature B.V,Cureus
• Subject: Antiretroviral drugs / Confidentiality / Data collection / Ethnicity / Genetics / HIV / HIV/AIDS / Human immunodeficiency virus / Infections / Infectious Disease / Patients / Population / Tuberculosis